Resources
Resources, News & MoreFeatured Resources
To highlight key information, the following articles have been summarized for readers:
➜ JACC Journal: Management of Acute and Recurrent Pericarditis
➜ Science Direct: Imaging-Guided Therapies for Pericardial Diseases
➜ European Heart Journal: 2015 ESC Guidelines for the Diagnosis & Management of Pericardial Diseases
Helpful resources from reputable nonprofit organizations:
➜ American Heart Association: Recurrent Pericarditis Podcast Series
Kiniksa Announces FDA Approval of Arcalyst
Aug 14, 2021 | Press Release, Resources, Treatment
US DATABASE STUDY OF CLINICAL BURDEN AND UNMET NEED IN RECURRENT PERICARDITIS
THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT
KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS
Mar 18, 2021 | Press Release, Resources, Treatment
PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS
RILONACEPT PREVENTS RECURRENT PERICARDITIS: RHAPSODY
IMAGING-GUIDED THERAPIES FOR PERICARDIAL DISEASES
IRAP STUDY
MANAGEMENT OF ACUTE AND RECURRENT PERICARDITIS

Dr. Allan Klein on the Cardiac Consult podcast
January 11, 2022 | Education, In The News, News, Podcast

Dona Winnowski on Community RadioExchange
December 31, 2021 | Education, In The News, News, Podcast

Olympic Coach Dawn Staley’s Personal Battle with Pericarditis

Kiniksa Announces FDA Approval of Arcalyst
August 14, 2021 | Press Release, Resources, Treatment

US DATABASE STUDY OF CLINICAL BURDEN AND UNMET NEED IN RECURRENT PERICARDITIS

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS
March 18, 2021 | Press Release, Resources, Treatment

PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS

RILONACEPT PREVENTS RECURRENT PERICARDITIS: RHAPSODY

IMAGING-GUIDED THERAPIES FOR PERICARDIAL DISEASES

IRAP STUDY
